title: [Evaluation of the quick diagnosis and treatment program for lung cancer].
abstract: OBJECTIVE
  To analyze the efficiency of the program of quick diagnosis and treatment (PDTR, programa de diagnóstico y tratamiento rápido) of lung cancer established in the Hospital de la Santa Creu i Sant Pau of Barcelona to review the epidemiology of lung cancer.
  
  
  METHODS
  Fifty-eight patients with lung cancer were studied. Twenty-nine of them were included in the program between October 2005 and May 2006, and the remaining were randomly selected among those diagnosed the year before (control group). Time between first visit, diagnosis and treatment and other variables (age, sex, histological type and TNM stage) were compared between groups.
  
  
  RESULTS
  Significant differences were found between the two groups. PDTR patients had a mean time between first visit and treatment of 26.7 days (Standard Deviation [SD]=13.6), whereas this was 84 days (SD=53) in the control group. The PDTR group had a lower TNM stage, but statistical significance was only found in N (lymph node involvement) (p=0.007).
  
  
  CONCLUSIONS
  Most patients included in the PDTR program spend less than 30 days between first visit and treatment, which represents a significant reduction in time (p<0.001). The effect on prognosis is controversial and will need long term studies.
authors.affiliation: Servicio de Radiodiagnóstico, Hospital de la Santa Creu i Sant Pau, Barcelona, España. egranell@santpau.es
authors.forename: E
authors.initials: E
authors.lastname: Granell
authors.forename: A
authors.initials: A
authors.lastname: Hidalgo
authors.forename: A
authors.initials: A
authors.lastname: Martínez
authors.forename: I
authors.initials: I
authors.lastname: Gich
authors.forename: I
authors.initials: I
authors.lastname: Bolívar
authors.forename: T
authors.initials: T
authors.lastname: Franquet
authors.forename: A
authors.initials: A
authors.lastname: Giménez
authors.forename: T
authors.initials: T
authors.lastname: Alepuz
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015397:Program Evaluation; D012189:Retrospective Studies; D013997:Time Factors